BRIEF-Novartis says U.S. wholesale acquisition cost of Rydapt for AML indication to be $7,495 for 14-day package
April 28, 2017 at 13:04 PM EDT
* Says U.S. wholesale acquisition cost of Rydapt for AML indication is $7,495 for 14-day package and $14,990 for 28-day package - spokeswoman Further company coverage:
